Roivant Sciences Ltd

ROIV

Market Cap$8.97B

Close$

Compare Roivant Sciences Ltd

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Roivant Sciences Ltd	2	0%	73%	-	0.1
Market Avg	54.3	1.27%	32%	-	1.3
Other Avg	333.2	0.49%	11%	3.9	0.8

$16.75

Target Price by Analysts

45.7% upsideRoivant Sciences Ltd Target Price Details

$-3.69

Current Fair Value

132.1% downside

Overvalued by 132.1% based on the discounted cash flow analysis.

Share Statistics

Market cap	$8.97 Billion
Enterprise Value	$2.80 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$5.73
Beta	1.03
Outstanding Shares	805,846,006
Avg 30 Day Volume	4,257,112

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	2.01
PEG	-0.13
Price to Sales	-
Price to Book Ratio	1.64
Enterprise Value to Revenue	22.76
Enterprise Value to EBIT	-2.68
Enterprise Value to Net Income	0
Total Debt to Enterprise	0.18
Debt to Equity	0.08

Revenue Sources

No data

ESG Score

No data

About Roivant Sciences Ltd